Politics

Federal appeals court to hear Louisiana challenge to mifepristone rules

The Hill reports that the Trump administration faces legal pressure as oral arguments approach over abortion pill regulations.

Updated Sep 6, 2026 · 18:18 UTC1 reports

The short version

A 5th U.S. Circuit Court of Appeals panel will hear arguments in a lawsuit brought by Louisiana challenging federal telehealth rules for mifepristone.[The Hill]
The legal challenge could impact nationwide telehealth and mail-order distribution of the medication, which has been used by more than 7.5 million Americans.[The Hill]
The Justice Department has requested pauses in related lawsuits while the FDA conducts an ongoing retrospective safety review.[The Hill]

A three-judge panel on the 5th U.S. Circuit Court of Appeals is scheduled to hear oral arguments in Louisiana's lawsuit regarding mifepristone distribution rules.[The Hill]
Louisiana sued over the FDA's telehealth rules, contending that the federal policy infringed upon state sovereignty and undercut its near-total abortion ban.[The Hill]
The Justice Department has asked federal courts to pause litigation involving mifepristone while the FDA finishes a retrospective safety analysis.[The Hill]
Lawsuits that could alter nationwide telehealth access to mifepristone are also moving forward in federal courts in Missouri and Texas.[The Hill]

Whether courts will grant the Justice Department's request to pause ongoing mifepristone lawsuits during the FDA safety evaluation.[The Hill]
The timeline and specific findings of the FDA's retrospective data analysis, which was estimated to take six months.[The Hill]

Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.